108 related articles for article (PubMed ID: 2409633)
1. A F(ab')2 fragment blocking study of the HLA-B14 antigen.
Darke C
Tissue Antigens; 1985 Apr; 25(4):177-86. PubMed ID: 2409633
[TBL] [Abstract][Full Text] [Related]
2. Antigenic determinants of the HLA-B7 molecule; Bw6- and B7-specific determinants are spatially separate.
Parham P
Immunogenetics; 1983; 18(1):1-16. PubMed ID: 6190743
[TBL] [Abstract][Full Text] [Related]
3. The HLA--B14 cross-reactive group.
Darke C
Tissue Antigens; 1980 Apr; 15(4):389-97. PubMed ID: 7466779
[TBL] [Abstract][Full Text] [Related]
4. A monoclonal antibody against an epitope common to HLA-b locus antigens.
Billing R; Lucero K
Hum Immunol; 1982 Jul; 4(4):351-7. PubMed ID: 6181038
[TBL] [Abstract][Full Text] [Related]
5. Association of HLA-Bw65 with two major complotypes.
Darke C; O'Neill GJ
Tissue Antigens; 1987 Jul; 30(1):11-7. PubMed ID: 3672489
[TBL] [Abstract][Full Text] [Related]
6. The binding of monoclonal antibodies to cell-surface molecules. A quantitative analysis with immunoglobulin G against two alloantigenic determinants of the human transplantation antigen HLA-A2.
Ways JP; Parham P
Biochem J; 1983 Nov; 216(2):423-32. PubMed ID: 6197968
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of responder cell activity in mixed leukocyte culture reactions. I. Evidence of cross-reactivity of B7-antibody with HLA-B8.
de Rooij-Doyer E; Bruning JW; van Rood JJ
Tissue Antigens; 1981 Sep; 18(3):154-65. PubMed ID: 7336421
[TBL] [Abstract][Full Text] [Related]
8. The inclusion of HLA-Bw42, Bw54 and Bw55 within the HLA-B14 cross-reactive group.
Darke C
Tissue Antigens; 1983 Mar; 21(3):246-53. PubMed ID: 6190262
[No Abstract] [Full Text] [Related]
9. HLA antigens: rabbit antisera reacting with all A series or all B series specificities.
Cresswell P; Ayres JL
Eur J Immunol; 1976 Feb; 6(2):82-8. PubMed ID: 786698
[TBL] [Abstract][Full Text] [Related]
10. Detection of HLA antigens on lymphoblastoid and epithelial cell lines and cross-reactivity of HLA-Cw5 and HLA-Cw8.
O'Toole CM; Lewis CM; Wolf E
Hum Immunol; 1983 Mar; 6(3):119-31. PubMed ID: 6841162
[TBL] [Abstract][Full Text] [Related]
11. New evidence for the existence of HLA-B14 subtypes. Linkage with different DR antigens.
Mueller-Eckhardt G; Mayr WR; Prel L; Mueller-Eckhardt C
Tissue Antigens; 1983 Jan; 21(1):58-61. PubMed ID: 6404003
[TBL] [Abstract][Full Text] [Related]
12. Epitopes and motifs of the HLA-B*14 allele family products and related HLA-B14 cross-reactive specificities.
Street J; Darke C
Int J Immunogenet; 2017 Oct; 44(5):225-233. PubMed ID: 28691368
[TBL] [Abstract][Full Text] [Related]
13. A cytotoxic human hybridoma monoclonal antibody (TrJ5) specific for HLA-B38(16) and -B39(16).
Ge J; Hannestad K
Hum Immunol; 1993 Mar; 36(3):168-71. PubMed ID: 7686545
[TBL] [Abstract][Full Text] [Related]
14. Shared V-region antigens and cross-reacting specificities of human IgG anti-F(ab')2 and anti-DNA antibodies.
Williams RC; Malone CC; Silvestris F
Clin Immunol Immunopathol; 1996 Aug; 80(2):194-203. PubMed ID: 8764565
[TBL] [Abstract][Full Text] [Related]
15. Blocking of HLA and B lymphocyte alloantigens with F (ab')2 fragments of rabbit antibodies.
Billing RJ; Honig R; Peterson P; Safani M; Terasaki PI
J Immunol; 1976 Nov; 117(5 Pt.2):2040-2. PubMed ID: 62805
[TBL] [Abstract][Full Text] [Related]
16. Novel HLA-B alleles associated with antigens in the 8C CREG.
Steiner NK; Gans CP; Kosman C; Baldassarre LA; Edson S; Jones PF; Rizzuto G; Pimtanothai N; Koester R; Mitton W; Ng J; Hartzman RJ; Hurley CK
Tissue Antigens; 2001 Apr; 57(4):373-5. PubMed ID: 11380951
[TBL] [Abstract][Full Text] [Related]
17. Fab2 fragments from HLA xenoantisera specifically block cytolysis mediated by HLA-AB alloantisera.
Belvedere M; Richiardi P; Pellegrino MA; Ferrone S
J Immunogenet; 1980 Jun; 7(3):215-9. PubMed ID: 6157749
[TBL] [Abstract][Full Text] [Related]
18. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ
Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
[TBL] [Abstract][Full Text] [Related]
19. Transformation of LMTK- cells with purified class I genes. V. Antibody-induced structural modification of HLA class I molecules results in potentiation of the fixation of a second monoclonal antibody.
Lemonnier FA; Le Bouteiller PP; Olive D; Malissen B; Mishal Z; Layet C; Dubreuil J; Caillol DH; Kourilsky FM; Jordan BR
J Immunol; 1984 Mar; 132(3):1176-82. PubMed ID: 6198381
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of monoclonal antibodies against HLA-A2 is due to antibody bivalency.
Holmes NJ; Parham P
J Biol Chem; 1983 Feb; 258(3):1580-6. PubMed ID: 6185487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
